Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1995 Apr;63(4):1329–1335. doi: 10.1128/iai.63.4.1329-1335.1995

Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1.

J H Powers 1, B L Buster 1, C J Reist 1, E Martin 1, M Bridges 1, W M Sutherland 1, R P Taylor 1, W M Scheld 1
PMCID: PMC173154  PMID: 7890390

Abstract

Under certain circumstances, soluble antigens, particulate antigens, and/or microorganisms have been shown to bind to primate erythrocytes via complement receptor 1 (CR1) in the presence of specific antibodies and complement. This immune adherence reaction, specific for CR1, can lead to neutralization of antigens in the circulation and their subsequent clearance from the blood. The present experiments utilized cross-linked monoclonal antibody complexes (heteropolymers) with specificity for both CR1 and either 35S-labeled herpes simplex virus capsid or Haemophilus influenzae as prototype viral and bacterial particulate antigens, respectively. In each case, the respective specific heteropolymers facilitated binding of the target antigens (> or = 70 to 90%) in vitro to erythrocytes in the absence of complement. Several experimental protocols were employed to demonstrate that heteropolymers mediate specific, rapid (> or = 30 s), and quantitative binding of prototypical particulate pathogens to human and monkey erythrocytes but not to sheep erythrocytes, which lack CR1. These results extend the potential use of the erythrocyte-heteropolymer system to the neutralization and clearance of particulate viral and bacterial pathogens from the blood.

Full Text

The Full Text of this article is available as a PDF (617.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxman F. J. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983 Feb;71(2):236–247. doi: 10.1172/JCI110764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cosio F. G., Shen X. P., Birmingham D. J., Van Aman M., Hebert L. A. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol. 1990 Dec 15;145(12):4198–4206. [PubMed] [Google Scholar]
  3. Edberg J. C., Kujala G. A., Taylor R. P. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation. J Immunol. 1987 Aug 15;139(4):1240–1244. [PubMed] [Google Scholar]
  4. Fanger M. W., Morganelli P. M., Guyre P. M. Bispecific antibodies. Crit Rev Immunol. 1992;12(3-4):101–124. [PubMed] [Google Scholar]
  5. Fearon D. T., Ruddy S., Schur P. H., McCabe W. R. Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med. 1975 May 1;292(18):937–940. doi: 10.1056/NEJM197505012921802. [DOI] [PubMed] [Google Scholar]
  6. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  7. Füst G., Petrás G., Ujhelvi E. Activation of the complement system during infections due to gram-negative bacteria. Clin Immunol Immunopathol. 1976 May;5(3):293–302. doi: 10.1016/0090-1229(76)90036-2. [DOI] [PubMed] [Google Scholar]
  8. Greenman R. L., Schein R. M., Martin M. A., Wenzel R. P., MacIntyre N. R., Emmanuel G., Chmel H., Kohler R. B., McCarthy M., Plouffe J. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA. 1991 Aug 28;266(8):1097–1102. [PubMed] [Google Scholar]
  9. Haase E. M., Campagnari A. A., Sarwar J., Shero M., Wirth M., Cumming C. U., Murphy T. F. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1991 Apr;59(4):1278–1284. doi: 10.1128/iai.59.4.1278-1284.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hebert L. A., Cosio G. The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int. 1987 Apr;31(4):877–885. doi: 10.1038/ki.1987.81. [DOI] [PubMed] [Google Scholar]
  11. Henry N. K., McLimans C. A., Wright A. J., Thompson R. L., Wilson W. R., Washington J. A., 2nd Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube. J Clin Microbiol. 1983 May;17(5):864–869. doi: 10.1128/jcm.17.5.864-869.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kimberly R. P., Edberg J. C., Merriam L. T., Clarkson S. B., Unkeless J. C., Taylor R. P. In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest. 1989 Sep;84(3):962–970. doi: 10.1172/JCI114259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Medof M. E., Iida K., Mold C., Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med. 1982 Dec 1;156(6):1739–1754. doi: 10.1084/jem.156.6.1739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. NELSON R. A., Jr The immune-adherence phenomenon; a hypothetical role of erythrocytes in defence against bacteria and viruses. Proc R Soc Med. 1956 Jan;49(1):55–58. [PMC free article] [PubMed] [Google Scholar]
  15. NELSON R. A., Jr The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 1953 Dec 18;118(3077):733–737. doi: 10.1126/science.118.3077.733. [DOI] [PubMed] [Google Scholar]
  16. Newcomb W. W., Brown J. C. Structure of the herpes simplex virus capsid: effects of extraction with guanidine hydrochloride and partial reconstitution of extracted capsids. J Virol. 1991 Feb;65(2):613–620. doi: 10.1128/jvi.65.2.613-620.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pietersz G. A., McKenzie I. F. Antibody conjugates for the treatment of cancer. Immunol Rev. 1992 Oct;129:57–80. doi: 10.1111/j.1600-065x.1992.tb01419.x. [DOI] [PubMed] [Google Scholar]
  18. Reist C. J., Combs M. J., Croft B. Y., Taylor R. P. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation. Eur J Immunol. 1993 Nov;23(11):3021–3027. doi: 10.1002/eji.1830231144. [DOI] [PubMed] [Google Scholar]
  19. Ross G. D., Yount W. J., Walport M. J., Winfield J. B., Parker C. J., Fuller C. R., Taylor R. P., Myones B. L., Lachmann P. J. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol. 1985 Sep;135(3):2005–2014. [PubMed] [Google Scholar]
  20. Schifferli J. A., Ng Y. C., Estreicher J., Walport M. J. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. J Immunol. 1988 Feb 1;140(3):899–904. [PubMed] [Google Scholar]
  21. Sikkema D. J., Murphy T. F. Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1992 Dec;60(12):5204–5211. doi: 10.1128/iai.60.12.5204-5211.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Taylor R. P., Reist C. J., Sutherland W. M., Otto A., Labuguen R. H., Wright E. L. In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor. J Immunol. 1992 Apr 15;148(8):2462–2468. [PubMed] [Google Scholar]
  23. Taylor R. P., Sutherland W. M., Reist C. J., Webb D. J., Wright E. L., Labuguen R. H. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3305–3309. doi: 10.1073/pnas.88.8.3305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Taylor R. P., Wright E. L., Pocanic F. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes. J Immunol. 1989 Dec 1;143(11):3626–3631. [PubMed] [Google Scholar]
  25. Washington J. A., 2nd, Ilstrup D. M. Blood cultures: issues and controversies. Rev Infect Dis. 1986 Sep-Oct;8(5):792–802. doi: 10.1093/clinids/8.5.792. [DOI] [PubMed] [Google Scholar]
  26. Werner A. S., Cobbs C. G., Kaye D., Hook E. W. Studies on the bacteremia of bacterial endocarditis. JAMA. 1967 Oct 16;202(3):199–203. [PubMed] [Google Scholar]
  27. Wilchek M., Bayer E. A. Biotin-containing reagents. Methods Enzymol. 1990;184:123–138. doi: 10.1016/0076-6879(90)84267-k. [DOI] [PubMed] [Google Scholar]
  28. Wilson J. G., Fearon D. T. Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus. Arthritis Rheum. 1984 Dec;27(12):1321–1328. doi: 10.1002/art.1780271201. [DOI] [PubMed] [Google Scholar]
  29. Wolff E. A., Esselstyn J., Maloney G., Raff H. V. Human monoclonal antibody homodimers. Effect of valency on in vitro and in vivo antibacterial activity. J Immunol. 1992 Apr 15;148(8):2469–2474. [PubMed] [Google Scholar]
  30. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES